Could targeting the macrophage urokinase-type plasminogen activator receptor be a bullseye for PET imaging of atherosclerotic plaque inflammation?

被引：0
|
作者：
Tarkin, Jason M. [1 ,3 ]
Goncalves, Isabel [2 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Sect Cardioresp Med, Level 6,Box 110,Hills Rd, Cambridge CB2 2QQ, England
[2] Lund Univ, Dept Cardiol & Clin Sci Malmo, Lund, Sweden
[3] Univ Cambridge, Sect Cardio Resp Med, Cambridge, England
来源：
ATHEROSCLEROSIS | 2022年 / 352卷
基金：
英国惠康基金; 瑞典研究理事会;
关键词：
Urokinase-type plasminogen activator receptor; Inflammation; Atherosclerosis; Positron emission tomography; UPAR EXPRESSION; SEVERITY; SYSTEM; CELLS;
D O I：
10.1016/j.atherosclerosis.2022.05.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 82
页数：3
相关论文
共 50 条
  • [31] Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding
    Dupont, Daniel Miotto
    Madsen, Jeppe Buur
    Hartmann, Roland Karl
    Tavitian, Bertrand
    Duconge, Frederic
    Kjems, Jorgen
    Andreasen, Peter Andre
    RNA, 2010, 16 (12) : 2360 - 2369
  • [32] Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus
    Li, Jingman
    Pan, Yuchen
    Li, Dan
    Xia, Xiaoyu
    Jiang, Qi
    Dou, Huan
    Hou, Yayi
    MOLECULAR IMMUNOLOGY, 2020, 127 : 38 - 45
  • [33] At the Interface of Fibrinolysis and Inflammation: The Role of Urokinase-Type Plasminogen Activator in the Leukocyte Extravasation Cascade
    Reichel, Christoph A.
    Kanse, Sandip M.
    Krombach, Fritz
    TRENDS IN CARDIOVASCULAR MEDICINE, 2012, 22 (07) : 192 - 196
  • [34] Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
    AboEl-Magd, Gehan Hassan
    Mabrouk, Maaly Mohamed
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (01) : 36 - 41
  • [35] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR TYPE-2 PLASMINOGEN-ACTIVATOR INHIBITOR COMPLEXES ARE NOT INTERNALIZED UPON BINDING TO THE UROKINASE-TYPE-PLASMINOGEN-ACTIVATOR RECEPTOR IN THP-1 CELLS - INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR TYPE-2 PLASMINOGEN-ACTIVATOR INHIBITOR COMPLEXES WITH THE CELL-SURFACE
    RAGNO, P
    MONTUORI, N
    ROSSI, G
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 233 (02): : 514 - 519
  • [36] Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes
    Xu, L. B.
    Chi, N.
    Shi, W.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 9518 - 9529
  • [37] Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma
    Casella, R
    Shariat, SF
    Monoski, MA
    Lerner, SP
    CANCER, 2002, 95 (12) : 2494 - 2499
  • [38] MOLECULAR-CLONING OF CDNA FOR THE BOVINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR
    REUNING, U
    LITTLE, SP
    DIXON, EP
    JOHNSTONE, EM
    BANG, NU
    THROMBOSIS RESEARCH, 1993, 72 (01) : 59 - 70
  • [39] Evaluation of urokinase-type plasminogen activator and its receptor in neointima of polyester vascular grafts
    Kowalewski, R
    Zimnoch, L
    Wojtukiewicz, MZ
    Glowinski, J
    Glowinski, S
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 (01) : 23 - 28
  • [40] Diagnostic Value of Serum Urokinase-Type Plasminogen Activator Receptor in Children With Acute Appendicitis
    Oztan, Mustafa Onur
    Gokmen, Aysegul Aksoy
    Arslan, Fatma Demet
    Cakir, Ebru
    Sayan, Ali
    Abay, Elif
    Kaya, Selcuk
    Koyluoglu, Gokhan
    PEDIATRIC EMERGENCY CARE, 2020, 36 (07) : 332 - 337
12345